Last reviewed · How we verify

NCT03191812

The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults

Completed NA Last updated 15 March 2022
What this trial tests

NA trial testing transcranial Direct Current Stimulation (tDCS) in Aging in 61 participants. Completed in 26 May 2021.

Timeline
26 May 2017
Primary endpoint
26 November 2019
26 May 2021

Quick facts

Lead sponsorHebrew SeniorLife
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposebasic science
Enrollment61
Start date26 May 2017
Primary completion26 November 2019
Estimated completion26 May 2021
Sites2 locations across United States, Israel

Drugs / interventions tested

Conditions studied

Sponsor

Hebrew SeniorLife — full company profile →

Who can join

65 and older, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The tDCS \& Dual Tasking study will compare the effects of transcranial Direct Current Stimulation (tDCS) targeting three different cortical regions (as well as sham stimulation) on dual task standing and walking in older adults with and without a recent history of recurrent falls.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Targeted tDCS Mitigates Dual-Task Costs to Gait and Balance in Older Adults.
    Zhou J, Manor B, Yu W, Lo OY, et al · · 2021 · cited 44× · PMID 34216034 · DOI 10.1002/ana.26156

Verify or expand the search:

Other trials of transcranial Direct Current Stimulation (tDCS)

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Hebrew SeniorLife trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03191812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing